Toxicological evaluation of micafungin ophthalmic solution in rabbit eyes

Journal of Ocular Pharmacology and Therapeutics

Volumn 21, Issue 2, 2005, Pages 149-156

  Hiraoka, Takahiro ^a   Wakabayashi, Taketoshi ^a   Kaji, Yuichi ^a   Nanbu, Patricia N ^a   Okamoto, Fumiki ^a   Kiuchi, Takahiro ^a   Fu, Beihua ^b   Oshika, Tetsuro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; LACTATE DEHYDROGENASE; MICAFUNGIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORNEA THICKNESS; DRUG INSTILLATION; DRUG SAFETY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; LACRIMAL FLUID; MALE; NONHUMAN; RABBIT; SLIT LAMP;

ANIMALS; CELL COUNT; CORNEA; ENDOTHELIUM, CORNEAL; INSTILLATION, DRUG; INTRAOCULAR PRESSURE; L-LACTATE DEHYDROGENASE; LIPOPROTEINS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; OPHTHALMIC SOLUTIONS; PEPTIDES, CYCLIC; RABBITS; TEARS; TOXICITY TESTS;

EID: 17744375967     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.149     Document Type: Article

References (31)

1. Hyndiuk, R.A., and Yee, R.W. Antifungal agents. In Tabbara, K.P., and Hyndiuk, R. A., ed., Infections of the Eye Boston, Little Brown, 1986:239-256.
2. Jones, B.R. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am. J. Ophthalmol. 79:719-751, 1975.
3. Ishibashi, Y. Keratomycosis in Japan reported from 1976 to 1980. Nippon Ganka Gakkai Zasshi 86:651-656, 1982.
4. Savani, D.V., Perfect, J.R., Cobo, L.M., et al. Penetration of new azole compounds in to the eye and efficacy in experimental Candida endophthalmitis. Antimicrob. Agents Chemother. 31:6-10, 1987.
5. Tawara, S., Ikeda, F., Maki, K., et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob. Agents Chemother. 44:57-62, 2000.
6. Ikeda, F., Wakai, Y., Matsumoto, S., et al. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob. Agents Chemother. 44:614-618, 2000.
7. Petraitis, V., Petraitiene, R., Groll, A.H., et al. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob. Agents Chemother. 46:1857-1869, 2002.
8. Matsumoto, S., Wakai, Y., Nakai, T., et al. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis. Antimicrob. Agents Chemother. 44:619-621, 2000.
9. Huang, A., Edwards, F., Bernard, E.M., et al. In vitro activity of the new semisynthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species. Eur. J. Clin. Microbiol. Infect. Dis. 9:697-699, 1990.
10. Vazquez, J.A., Lynch, M., and Sobel, J.D. In vitro activity of a new pneumocandin antifungal agent, L-733, 560 against azole-susceptible and -resistant Candida and Torulopsis species. Antimicrob. Agents Chemother. 39:2689-2691, 1995.
11. Verweij, P.E., Oakley, K.L., Morrissey, J., et al. Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis. Antimicrob. Agents Chemother. 42:873-878, 1998.
12. Tomishima, M., Ohki, H., Yamada, A., et al. FK463, a novel water-soluble echinocandin lipopeptide: Synthesis and antifungal activity. J. Antibiot. 52:674-676, 1999.
13. National Research Council, Committee on the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, Commission on Life Sciences. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC 1996.
14. Johns, K.J., and O'Day, D.M. Pharmacologic management of keratomycoses. Surv. Ophthalmol. 33:178-88, 1988.
15. Feenstra, R.P., and Tseng, S.C. What is actually stained by rose bengal? Arch. Ophthalmol. 110:984-993, 1992.
16. Matsumoto, Y. The effects of topically applied drugs on the abraded rabbit cornea. Nippon Ganka Gakkai Zasshi 91:72-79, 1987.
17. Thomas, A.H. Suggested mechanisms for the antimycotic activity of the polyene antibiotics and the N-substituted imidazoles. J. Antimicrob. Chemother. 17:269-279, 1986.
18. Foster, C.S., Lass, J.H., Moran-Wallace, K., et al. Ocular toxicity of topical antifungal agents. Arch. Ophthalmol. 99:1081-1084, 1981.
19. O'Day, D.M., Ray, W.A., Head, W.S., et al. Influence of the corneal epithelium on the efficacy of topical antifungal agents. Invest. Ophthalmol. Vis. Sci. 25:855-859, 1984.
20. O'Day, D.M., Head, W.S., Robinson, R.D., et al. Corneal penetration of topical amphotericin B and natamycin. Curr. Eye. Res. 5:877-882, 1986.
21. Foster, C.S. Miconazole therapy for keratomycosis. Am. J. Ophthalmol. 91:622-629, 1981.
22. Fitzsimons, R., and Peters, A.L. Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. Am. J. Ophthalmol. 101:605-608, 1986.
23. Panda, A., Sharma, N., and Angra, S.K. Topical fluconazole therapy of Candida keratitis. Cornea 15:373-375, 1996.
24. Behrens-Baumann, W., Klinge, B., and Ruchel, R. Topical fluconazole for experimental Candida keratitis in rabbits. Br. J. Ophthalmol 74:40-42, 1990.
25. Leck, A.K., Thomas, P.A., Hagan, M., et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br. J. Ophthalmol. 86:1211-1215, 2002.
26. Wang, L., Zhang, Y., Wang, Y., et al. Spectrum of mycotic keratitis in China. Chung Hua Yen Ko Tsa Chih 36:138-140, 2000.
27. Chander, J., and Sharma, A. Prevalence of fungal corneal ulcers in northern India. Infection 22:207-209, 1994.
28. Hitchcock, C.A., Pye, G.W., Troke, P.F., et al. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965, 1993.
29. Ruhnke, M., Eigler, A., Tennagen, I., et al. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32:2092-2098, 1994.
30. Kahan, I.L., and Ottovay, E. Lactate dehydrogenase of tears and corneal epithelium. Exp. Eye. Res. 20:129-133, 1975.
31. Debono, M., and Gordee, R.S. Antibiotics that inhibit fungal cell wall development. Annu. Rev. Microbiol. 48:471-497, 1994.